Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC

NCT02271009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhino-Conjunctivitis

Interventions

DRUG: AllerT
DRUG: Placebo

Sponsor

Anergis

Collaborators

[object Object]